TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17029347

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tirilazad
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Other therapies (hemodynamic maneuvers, magnesium, statins, endothelin antagonists, steroid drugs, anticoagulant/antiplatelet agents, intrathecal fibrinolytic drugs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calcium channel antagonists (nicardipine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rescue therapy (balloon angioplasty, intraarterial vasodilating agents)
Number of subjects: 0
Study: 12870775

Group type: EXPERIMENTAL
Intervention: Liquid meals
Number of subjects: 251

Group type: COMPARATOR
Intervention: Solid meals
Number of subjects: 251
Study: 10587835

Group type: EXPERIMENTAL
Intervention: Multidisciplinary outpatient diabetes care management delivered by a diabetes nurse educator, psychologist, nutritionist, and pharmacist in cluster visit settings for 6 months.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 8598090

Group type: EXPERIMENTAL
Intervention: Algorithm-guided mapping (group 2B)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard mapping (group 2A)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Radiofrequency catheter ablation
Number of subjects: 89
Study: 1928658

Group type: EXPERIMENTAL
Intervention: SR 2640
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 6614279

Group type: EXPERIMENTAL
Intervention: Dental setting
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medical setting
Number of subjects: 60
Study: 31604630

Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure
Number of subjects: 0
Study: 28766740

Group type: EXPERIMENTAL
Intervention: Experiential learning
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional PowerPoint learning
Number of subjects: 12
Study: 27253231

Group type: EXPERIMENTAL
Intervention: 24-hour infusion of 20 mg nafamostat mesilate
Number of subjects: 382

Group type: EXPERIMENTAL
Intervention: 6-hour infusion of 20 mg nafamostat mesilate
Number of subjects: 382

Group type: COMPARATOR
Intervention: Control group (6-hour infusion)
Number of subjects: 382
Study: 24382719

Group type: EXPERIMENTAL
Intervention: Traditional rehabilitation program with early range of motion
Number of subjects: 124

Group type: COMPARATOR
Intervention: Immobilization group with delayed range of motion for six weeks
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both rehabilitation protocols
Number of subjects: 124
Study: 21847539

Group type: EXPERIMENTAL
Intervention: Topical amitriptyline, ketamine, and lidocaine (AKL) applied three times a day until 2 weeks post-radiotherapy.
Number of subjects: 16
Study: 21106059

Group type: EXPERIMENTAL
Intervention: Active treatments
Number of subjects: 281

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 281
Study: 18201610

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (75 turbidity‐reducing units)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 15977132

Group type: EXPERIMENTAL
Intervention: Mix of attributes approach (experimental group)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 140
Study: 12563136

Group type: EXPERIMENTAL
Intervention: Uterine artery embolization (UAE)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Hysterectomy
Number of subjects: 56
Study: 10882317

Group type: EXPERIMENTAL
Intervention: Early Intervention Program (EIP)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Traditional Public Health Nursing (TPHN)
Number of subjects: 121
Study: 8771420

Group type: EXPERIMENTAL
Intervention: Early endoscopy combined with endoscopic therapy for patients with bloody aspirate
Number of subjects: 325

Group type: COMPARATOR
Intervention: Delayed endoscopy for patients with clear or coffee-grounds aspirate
Number of subjects: 325
Study: 1466212

Group type: EXPERIMENTAL
Intervention: Lidocaine 1% (1 mg.kg‐1)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Saline 0.9%
Number of subjects: 200
Study: 2582377

Group type: EXPERIMENTAL
Intervention: RS4
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: TX
Number of subjects: 19
Study: 31897406

Group type: EXPERIMENTAL
Intervention: Henna oil
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Olive oil
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 108
Study: 29331381

Group type: COMPARATOR
Intervention: Abiraterone acetate (AA) or enzalutamide (E) after ADT alone
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate (AA) or enzalutamide (E) after ADT+D
Number of subjects: 102
Study: 27736198

Group type: EXPERIMENTAL
Intervention: Nephrostomy drainage (Group 1: 8F or 10F)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Ureteral stent (Group 2)
Number of subjects: 30
Study: 25295434

Group type: EXPERIMENTAL
Intervention: Specialized treatment (CAU + PEP + psychiatric consultation or cognitive‐behavioral therapy)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Primary treatment (CAU or CAU + PEP)
Number of subjects: 146
Study: 21742445

Group type: EXPERIMENTAL
Intervention: Behavioral treatment + naltrexone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study: 20675864

Group type: EXPERIMENTAL
Intervention: Low energy laser therapy (Group A, n=35)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Vacuum therapy combined with Ultra Reiz current (Group C, n=32)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Ultrasound therapy (Group B, n=27)
Number of subjects: 94
Study: 18207595

Group type: EXPERIMENTAL
Intervention: Prone position
Number of subjects: 20

Group type: COMPARATOR
Intervention: Supine position
Number of subjects: 20
Study: 15749735

Group type: EXPERIMENTAL
Intervention: Magnesium (80 mg kg(‐1) followed by infusion at 2 g h(‐1))
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (no magnesium)
Number of subjects: 9
Study: 12884643

Group type: EXPERIMENTAL
Intervention: Statins (specific type not mentioned, but atorvastatin is referenced for cost comparison)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atorvastatin
Number of subjects: 0
Study: 10640259

Group type: EXPERIMENTAL
Intervention: 2.5 mg zolmitriptan
Number of subjects: 49784

Group type: EXPERIMENTAL
Intervention: 5 mg zolmitriptan
Number of subjects: 49784
Study: 8876359

Group type: EXPERIMENTAL
Intervention: Inosine pranobex (1 g orally 3 times a day for 6 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 2054277

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study: 6696302

Group type: EXPERIMENTAL
Intervention: Oxacillin 500 mg qid for five days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31314106

Group type: EXPERIMENTAL
Intervention: Inhalation Injury (INHI)
Number of subjects: 345

Group type: COMPARATOR
Intervention: No Inhalation Injury (No INHI)
Number of subjects: 345

Group type: EXPERIMENTAL
Intervention: Overall analysis
Number of subjects: 345
Study: 28699267

Group type: EXPERIMENTAL
Intervention: Lucerastat 1,000 mg b.i.d. for 12 weeks
Number of subjects: 10

Group type: COMPARATOR
Intervention: Enzyme Replacement Therapy (ERT) only
Number of subjects: 10
Study: 26758265

Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery (arthroscopic debridement and partial resection of degenerative knee tissues) in addition to optimised non-operative therapy
Number of subjects: 168

Group type: COMPARATOR
Intervention: Optimised non-operative therapy only
Number of subjects: 168
Study: 24022643

Group type: EXPERIMENTAL
Intervention: Topical ketorolac 0.5 % solution
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Oral acetazolamide 250 mg/day
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (no agent)
Number of subjects: 80
Study: 22231571

Group type: EXPERIMENTAL
Intervention: Night splinting
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nerve and tendon gliding exercises
Number of subjects: 20

Group type: COMPARATOR
Intervention: Advice to remain active
Number of subjects: 20
Study: 20669670

Group type: EXPERIMENTAL
Intervention: Ginaton 1 mg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 60
Study: 17505565

Group type: EXPERIMENTAL
Intervention: Triple therapy (PPI, clarithromycin, amoxicillin)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Triple therapy (PPI, clarithromycin, metronidazole)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Triple therapy (PPI, amoxicillin, metronidazole)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Quadruple therapy (PPI, bismuth, metronidazole, tetracycline) for 7-10 days
Number of subjects: 17
Study: 17492326

Group type: EXPERIMENTAL
Intervention: Telemedicine-based collaborative care
Number of subjects: 395
Study: 15017231

Group type: EXPERIMENTAL
Intervention: Intraplaque electromotive administration of 5 mg verapamil and 8 mg dexamethasone
Number of subjects: 96

Group type: COMPARATOR
Intervention: Electromotive administration of 2% lidocaine
Number of subjects: 96
Study: 11386773

Group type: EXPERIMENTAL
Intervention: Silastic interposition arthroplasty with crossed intrinsic transfer
Number of subjects: 36

Group type: COMPARATOR
Intervention: Silastic interposition arthroplasty without crossed intrinsic transfer
Number of subjects: 36
Study: 9241405

Group type: EXPERIMENTAL
Intervention: High phenylalanine supplement over 3 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 16
Study: 8257482

Group type: EXPERIMENTAL
Intervention: Periconceptional multivitamin supplementation
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: Combined vitamin I‐II sample
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: Combined trace element I‐II sample
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: Total trace element sample
Number of subjects: 4156

Group type: EXPERIMENTAL
Intervention: Total vitamin sample
Number of subjects: 4156
Study: 3329102

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg/day before breakfast for six months
Number of subjects: 19

Group type: COMPARATOR
Intervention: Piroxicam 20 mg/day before breakfast for six months
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg/day before breakfast from 7th to 12th month
Number of subjects: 19
Study: 30975666

Group type: EXPERIMENTAL
Intervention: Telemedical coaching (TMC)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group 1 (C1)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control group 2 (C2)
Number of subjects: 104

Group type: COMPARATOR
Intervention: All groups (including TMC, C1, C2)
Number of subjects: 104
Study: 28689608

Group type: EXPERIMENTAL
Intervention: Cooking Matters for Adults (CM)
Number of subjects: 332
Study: 25726558

Group type: EXPERIMENTAL
Intervention: Multidisciplinary team (MDT) approach in diagnosis of IPF
Number of subjects: 0
Study: 24169422

Group type: EXPERIMENTAL
Intervention: Intervention to alleviate effects of the initial interview
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention to enhance effects of the initial interview
Number of subjects: 0

Group type: COMPARATOR
Intervention: Initial interview discussing a distressing event
Number of subjects: 0
Study: 21539403

Group type: EXPERIMENTAL
Intervention: Intranasal administration of lisdexamfetamine dimesylate 50 mg
Number of subjects: 18

Group type: COMPARATOR
Intervention: Oral administration of lisdexamfetamine dimesylate 50 mg
Number of subjects: 18
Study: 19359665

Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Rosuvastatin with caffeine
Number of subjects: 21
Study: 17042717

Group type: EXPERIMENTAL
Intervention: Clodronate 800 mg daily
Number of subjects: 5596

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5596
Study: 15250197

Group type: EXPERIMENTAL
Intervention: Tongfengkang (TFK)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Indomethacin and Allopurinol (Control)
Number of subjects: 40
Study: 12474071

Group type: EXPERIMENTAL
Intervention: Rye and orange juice group (33 volunteers)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fortified wheat bread and apple juice group (31 volunteers)
Number of subjects: 64
Study: 9664993

Group type: EXPERIMENTAL
Intervention: cyclosporine and azathioprine (group A)
Number of subjects: 27

Group type: COMPARATOR
Intervention: prednisone, cyclosporine, and azathioprine (group B)
Number of subjects: 27
Study: 8566979

Group type: EXPERIMENTAL
Intervention: 0.15% cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.3% cream
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.5% solution
Number of subjects: 90
Study: 2528439

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide/potassium hydroxyquinoline sulphate cream with hydrocortisone
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Benzoyl peroxide/potassium hydroxyquinoline sulphate cream without hydrocortisone
Number of subjects: 107

Group type: COMPARATOR
Intervention: Aqueous astringent cream base alone
Number of subjects: 107

Group type: COMPARATOR
Intervention: Benzoyl peroxide alcoholic gel
Number of subjects: 107
Study: 4911743

Group type: EXPERIMENTAL
Intervention: Diphenoxylate hydrochloride
Number of subjects: 45
Study: 30596467

Group type: EXPERIMENTAL
Intervention: B-APQ
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Presence of chronic illness
Number of subjects: 0
Study: 30843602

Group type: EXPERIMENTAL
Intervention: BFR-leg (blood flow restriction; pressure: ∼180 mmHg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CON-leg (control leg, trained without BFR)
Number of subjects: 10
Study: 27917462

Group type: EXPERIMENTAL
Intervention: Previously transfused patients
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Splenectomised patients
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Patients with saturated transferrin
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Patients with >20 prior transfusions
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: NTDT patients with TfSat >70%
Number of subjects: 166
Study: 26031204

Group type: EXPERIMENTAL
Intervention: Single application of five warming devices (Azuki no Chikara, Eye Hot R, hot towel, Hot Eye Mask, Memoto Este)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Repeated application of Azuki no Chikara (non‐wet device)
Number of subjects: 20
Study: 23562353

Group type: EXPERIMENTAL
Intervention: DNA copy number levels and mRNA expression
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: mRNA expression and protein expression
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Copy number levels and mRNA expression
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Overall expression of cyclin B1
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: hsa-miR-29c
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: CCNB1 copy number
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Cyclin B1 copy number aberrations
Number of subjects: 251
Study: 21927856

Group type: EXPERIMENTAL
Intervention: Amino acid infusion (200 ml h(‐1) of a mixture of 18 amino acids)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline infusion (200 ml h(‐1))
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Amino acid infusion
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Amino acid infusion and saline infusion
Number of subjects: 22
Study: 19395954

Group type: EXPERIMENTAL
Intervention: Integrated reperfusion network
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prehospital thrombolysis, facilitated PCI, prompt transfer to institutions with primary PCI capabilities
Number of subjects: 0
Study: 16122784

Group type: EXPERIMENTAL
Intervention: EBS Multi/Compolute (3M Espe)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Syntac/Variolink II low (Ivoclar Vivadent)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Both adhesives
Number of subjects: 31
Study: 16618688

Group type: EXPERIMENTAL
Intervention: Education/orientation program
Number of subjects: 0
Study: 11682389

Group type: EXPERIMENTAL
Intervention: Propofol sedation with BIS target of 75
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Propofol sedation with BIS target of 80
Number of subjects: 30
Study: 9202917

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (50%) in oxygen
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fentanyl with preoxygenation
Number of subjects: 50
Study: 7970548

Group type: EXPERIMENTAL
Intervention: Topical timolol and atropine combined
Number of subjects: 0

Group type: COMPARATOR
Intervention: Topical timolol alone
Number of subjects: 0
Study: 3310418

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (H.) in combination with systemic or intravesical chemotherapy
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Intravesical hyaluronidase (H.) with mitomycin C
Number of subjects: 260

Group type: COMPARATOR
Intervention: Adjuvant intravesical mitomycin C alone
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Adjuvant intravesical hyaluronidase (H.)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (H.) during arterial perfusion in colorectal cancer
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Hyaluronidase (H.) with 5‐FU in colorectal cancer stem cell assays
Number of subjects: 260
Study: 31899533

Group type: EXPERIMENTAL
Intervention: Bevacizumab use among oncologists' peers in 2005 to 2006
Number of subjects: 44712

Group type: EXPERIMENTAL
Intervention: Communities with the highest rates of bevacizumab use in 2005 to 2006
Number of subjects: 44712
Study: 30921225

Group type: EXPERIMENTAL
Intervention: Totally robotic right hemicolectomy (TRRH)
Number of subjects: 192

Group type: COMPARATOR
Intervention: Robotic-assisted right hemicolectomy (RARH)
Number of subjects: 192
Study: 28135023

Group type: EXPERIMENTAL
Intervention: NSAIDs and/or paracetamol
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: NSAIDs only
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Paracetamol only
Number of subjects: 482

Group type: EXPERIMENTAL
Intervention: Both NSAIDs and paracetamol
Number of subjects: 482
Study: 26249767

Group type: EXPERIMENTAL
Intervention: LEVO 200 µg once-daily
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: LEVO 200 µg twice-daily
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: LEVO 200 µg once-daily vs LEVO 200 µg twice-daily
Number of subjects: 78
Study: 24242260

Group type: EXPERIMENTAL
Intervention: HIV stigma reduction intervention
Number of subjects: 507

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 507
Study: 21985524

Group type: EXPERIMENTAL
Intervention: Smoking prisoners
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Aboriginal prisoners
Number of subjects: 425
Study: 19857150

Group type: EXPERIMENTAL
Intervention: Anticoagulation therapy with low-molecular-weight heparins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VTE prophylaxis and/or prompt treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aggressive VTE management and strategies
Number of subjects: 0
Study: 17029611

Group type: EXPERIMENTAL
Intervention: Acute tryptophan increase (ATI)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Acute tryptophan depletion (ATD)
Number of subjects: 29
Study: 15272643

Group type: EXPERIMENTAL
Intervention: Perindopril 4 mg/day (group A)
Number of subjects: 24

Group type: COMPARATOR
Intervention: No intervention (group B)
Number of subjects: 24
Study: 11141646

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9549924

Group type: COMPARATOR
Intervention: CMV‐IgG 100 mg/kg/week
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: HDIgG 400 mg/kg/week
Number of subjects: 128
Study: 8172750

Group type: EXPERIMENTAL
Intervention: iopentol
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: iohexol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Calcium channel blockers (pre-existing condition)
Number of subjects: 60
Study: 2830688

Group type: EXPERIMENTAL
Intervention: Low-dose recombinant interferon-alpha-2C (rIFNa2C)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30474306

Group type: EXPERIMENTAL
Intervention: Real PBM (Photobiomodulation)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham PBM (Control)
Number of subjects: 30
Study: 25264016

Group type: EXPERIMENTAL
Intervention: Maitland mobilization and exercises
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mulligan mobilization and exercises
Number of subjects: 60

Group type: COMPARATOR
Intervention: Exercises only
Number of subjects: 60
Study: 23834538

Group type: COMPARATOR
Intervention: Upper Body Compression Garments (UBCG)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (no shirt or sports training bra)
Number of subjects: 7
Study: 21849980

Group type: EXPERIMENTAL
Intervention: Active transcranial magnetic stimulation (TMS) at 10 Hz, specific details on dosage and duration not available.
Number of subjects: 39
Study: 17912747

Group type: EXPERIMENTAL
Intervention: Endurance training for 3 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 21
Study: 16504481

Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 79
Study: 12687650

Group type: EXPERIMENTAL
Intervention: MTHFR(C677T) genotype CC
Number of subjects: 2788

Group type: EXPERIMENTAL
Intervention: MTHFR(C677T) genotype CT
Number of subjects: 2788

Group type: EXPERIMENTAL
Intervention: MTHFR(C677T) genotype TT
Number of subjects: 2788

Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 2788

Group type: COMPARATOR
Intervention: Men compared to women
Number of subjects: 2788
Study: 12742280

Group type: EXPERIMENTAL
Intervention: Tezosentan (25 mg/h for 1 h, then 50 mg/h for 23 to 47 h)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Tezosentan
Number of subjects: 193
Study: 10797113

Group type: EXPERIMENTAL
Intervention: Circuit weight training (CWT) program
Number of subjects: 13